Note 2: Acquisitions On March 18, 2019, the Company entered into an Asset and Franchise Purchase Agreement under which (i) the Company repurchased from the seller one operating franchise in West Covina, California and (ii) the parties agreed to terminate a second franchise agreement for an operating franchise. The Company operates the remaining franchise as a company-managed clinic. The total purchase price for the transaction was $30,000, less $3,847 of net deferred revenue resulting in total purchase consideration of $26,153. On July 9, 2019, the Company entered into an Asset and Franchise Purchase Agreement under which the Company repurchased from the seller one operating franchise in Phoenix, Arizona. The Company operates the franchise as a company-owned clinic. The total purchase price for the transaction was $400,000, less $9,835 of net deferred revenue resulting in total purchase consideration of $390,165. On July 17, 2019, the Company entered into an Asset and Franchise Purchase Agreement under which the Company repurchased from the seller three operating franchises in Savannah, Georgia, Pooler, Georgia and Bluffton, South Carolina. The Company operates the franchises as company-owned clinics. The total purchase price for the transaction was $1,604,918, less $13,449 of net deferred revenue resulting in total purchase consideration of $1,591,469. On August 1, 2019, the Company entered into an Asset and Franchise Purchase Agreement under which the Company repurchased from the seller one operating franchise in Sayebrook, South Carolina. The Company operates the franchise as a company-owned clinic. The total purchase price for the transaction was $727,414, less $5,236 of net deferred revenue resulting in total purchase consideration of $722,178. On August 15, 2019, the Company entered into an Asset and Franchise Purchase Agreement under which the Company repurchased from the seller one operating franchise in Chula Vista, California. The Company operates the franchise as a company-managed clinic. The total purchase price for the transaction was $310,000, less $4,328 of net deferred revenue resulting in total purchase consideration of $305,672. Purchase Price Allocation The following summarizes the aggregate estimated fair values of the assets acquired and liabilities assumed during 2019 as of the acquisition date: Property and equipment $ 149,542 Operating lease right-of-use asset 1,219,244 Intangible assets 1,989,169 Total assets acquired 3,357,955 Goodwill 898,031 Deferred revenue (123,254 ) Operating lease liability - current portion (208,226 ) Operating lease liability - net of current portion (858,161 ) Deferred tax liability (11,410 ) Bargain purchase gain (19,298 ) Net purchase price $ 3,035,637 Intangible assets in the table above consist of reacquired franchise rights of $1,479,794 amortized over an estimated useful life of three to four years and customer relationships of $509,375 amortized over an estimated useful life of two years. Goodwill was established due primarily to synergies and benefits expected to be gained from leveraging the Companys existing operations and infrastructures, as well as the expected associated revenue and cash flow projections. Goodwill has been allocated to the Companys Corporate Clinics segment based on such expected benefits. Goodwill related to the acquisition is expected to be deductible for income tax purposes over the next 15 years. The purchase price allocation is preliminary, and the Company expects to finalize the allocation during the fourth quarter of 2019. Pro Forma Results of Operations (Unaudited) The following table summarizes selected unaudited pro forma condensed consolidated statements of operations data for the three and nine months ended September 30, 2019 and 2018 as if the acquisitions in 2019 had been completed on January 1, 2018. Pro Forma for the Three Months Ended Pro Forma for the Nine Months Ended September 30, 2019 September 30, 2018 September 30, 2019 September 30, 2018 Revenues, net $ 12,898,252 $ 9,950,098 $ 35,995,375 $ 28,876,720 Net income (loss) $ 596,980 $ (266,524 ) $ 1,837,801 $ (424,422 ) This selected unaudited pro forma consolidated financial data is included only for the purpose of illustration and does not necessarily indicate what the operating results would have been if the acquisitions had been completed on that date. Moreover, this information is not indicative of what the Companys future operating results will be. The information for 2018 and 2019 prior to the acquisitions is included based on prior accounting records maintained by the acquired clinics. In some cases, accounting policies differed materially from accounting policies adopted by the Company following the acquisition. For 2018, this information includes actual data recorded in the Companys financial statements for the period subsequent to the date of the acquisition. The Companys condensed consolidated statements of operations for the three months ended September 30, 2019 include net revenue and net loss of approximately $489,000 and $1,000, respectively, attributable to the acquisitions. The Companys consolidated statements of operations for the nine months ended September 30, 2019 include net revenue and net loss of approximately $562,000 and $14,000, respectively, attributable to the acquisitions. The pro forma amounts included in the table above reflect the application of accounting policies and adjustment of the results of the clinics to reflect the additional depreciation and amortization that would have been charged assuming the fair value adjustments to property and equipment and intangible assets had been applied from January 1, 2018. The pro forma earnings do not include adjustments related to acquisition-related costs incurred in 2019, which were not material.